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ABSTRACT 18 
The aim of this investigation was to characterize MBLs in P. aeruginosa isolates from 19 
Zagreb, Croatia. 20 
100 P. aeruginosa isolates with reduced susceptibility to either imipenem or meropenem were 21 
tested for the production of MBLs by E test MBL. The susceptibility to a wide range of 22 
antibiotics was determined by broth microdilution method. The presence of blaMBL genes was 23 
detected by PCR.  Hydrolysis of 0.1 mM imipenem by crude enzyme preparations of β-24 
lactamases was monitored by UV spectrophotometer.. Outer membrane proteins were 25 
prepared and analysed by SDS-PAGE.  26 
Six  out of 100 isolates were positive for MBLs by E test. All strains were resistant to 27 
gentamicin, ceftazidime and cefotaxime and all except of one to imipenem.  28 
Six strains positive for MBLs in E test were identified as VIM MBLs producers by PCR. 29 
Sequencing of blaVIM genes revealed the production of VIM-2 β -lactamase in all six strains.   30 
This investigation proved the occurence of VIM-2 β-lactamase among P. aeruginosa strains 31 
from Zagreb, Croatia. VIM-2 β -lactamase with similar properties was previously described in 32 
another region of Croatia, Italy, France, Spain, Greece, Taiwan and South Korea suggesting 33 
that this type of enzyme is widespread in Mediteranean region of Europe and in Far East.  34 
Key words: meropenem, imipenem, metallo-β-lactamases, resistance, Pseudomonas 35 
aeruginosa 36 
INTRODUCTION 37 
Carbapenemases may be defined as β-lactamases that significantly hydrolyse at least 38 
imipenem or/and meropenem [1]. The most clinically significant carbapenemases belong to 39 
class B [2]. They are metallo- enzymes which require zinc as a cofactor and comprise four 40 
families: IMP, VIM, SPM, GIM and SIM [3-6]. The VIM-type enzymes appear to the most 41 
prevalent in Europe and Korea, and at least 10 different variants have been described [4].  The 42 
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worldwide spread of acquired metallo-β-lactamases (MBLs) in gram-negative bacilli has 43 
become a great concern. MBLs possess a broad hydrolysis profile that includes carbapenems 44 
and almost all extended-spectrum β-lactams except of aztreonam. Carbapenem resistant 45 
strains of P.aeruginosa have been detected with increasing frequency in hospitals in Zagreb 46 
and pose serious therapeutic problem. The aim of this investigation was to characterize MBLs 47 
in P. aeruginosa isolates from Zagreb, Croatia. 48 
 49 
MATERIALS AND METHODS 50 
Bacteria 51 
100 P. aeruginosa isolates with reduced susceptibility to either imipenem or meropenem were 52 
tested for the production of MBLs by E test MBL (Solna, Sweden). The strains were isolated 53 
during 2002 to  2004 at the Clinical Hospital Center Zagreb and University Hospital Merkur 54 
in Zagreb from various clinical specimens and wards (Table 1). Isolates were identified by 55 
conventional biochemical methods.  56 
E test MBL test 57 
The strip (AB Biodisk, Solna, Sweden) contains a double-sided seven-dilution range of 58 
imipenem (4 to 256 mg/L) and imipenem (1 to 64 mg/L) in combination with a fixed 59 
concentration of EDTA. An overnight culture of the test strains in Mueller-Hinton (MH) broth 60 
was diluted to match the turbidity of 0.5 McFarland, swabbed on the plates of MH agar and 61 
the plates were incubated at 35°C. A decrease of imipenem MIC by ≥3 twofold dilutions in 62 
the presence of EDTA was interpreted as being suggestive of MBL production [7].   63 
Susceptibility testing 64 
The susceptibility to a wide range of antibiotics was determined by twofold broth 65 
microdilution method in cation supplemented MH broth in 96 well microtiter plates according 66 
to CLSI [8]. The inoculum size was 5 x105 CFU/ml. The plates were incubated for 18 h at 37 67 
 4
°C. The strains with MICs below the resistance breakpoint were tested with higher inoculum 68 
of 108 CFU/ml as well. The test was performed in triplicate. P. aeruginosa ATCC 27853 was 69 
used for quality control. Antibiotic powders were obtained from the following manufacturers: 70 
ceftazidime, gentamicin and clavulanic acid-Pliva, Zagreb; cefotaxime-Belupo, Koprivnica; 71 
cefepime-Bristol Myers Squibb, Zagreb; imipenem-MSD, Zagreb; meropenem-AstraZeneca, 72 
Zagreb.  73 
Enzyme characterization 74 
The bacterial cells were pelleted from exponential phase cultures in Lurian-Bentoni  (LB) 75 
broth by centrifugation at 6000 g. The pellet was washed and resuspended in cation 76 
supplemented phospate buffer (0.1 mM, pH 7). Enzymes were released by sonication in ice 77 
bath. Cell debris was removed by centrifugation at 10 000 g and supernatant was stored at -78 
20°C as crude enzyme preparation. Hydrolysis of 0.1 mM imipenem by crude enzyme 79 
preparations of β-lactamases was monitored by UV spectrophotometer at 298 nm. The change 80 
of absorbance was recorded. Inhibition of enzyme activity was determined by 2 mM EDTA. 81 
Enzyme activity was expressed as nmol of substrate hydrolyzed per minute expressed 82 
relatively to the total protein content of the sample. Concentration of the protein in the 83 
samples was determined with a commercial method (BioRad). 84 
Analytical isoelectric focusing (IEF) 85 
IEF was performed according to Matthew et al  [9].The organisms were grown overnight in 86 
BHI broth, collected by centrifugation and β-lactamases were extracted from bacteria by 87 
sonication. Cell debris was removed by centrifugation at 14 000 g. Supernatant was used as 88 
crude enzyme. Isoelectric focusing was performed on polyacrylamide gels (acrylamide 7%, 89 
bis-acrylamide 0.2%) containing ampholines with a pH range of 3.5 to 10. The β-lactamases 90 
were detected by staining of the gel  with nitrocefin, following IEF.  β-lactamases of known 91 
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pI (isoelectric point) were used as standards: TEM-1, TEM-2, SHV-1, SHV-2, SHV-4 and 92 
SHV-5. 93 
 94 
Polymerase chain reaction and sequencing of blaVIM genes 95 
The presence of blaVIM and  blaIMP genes was tested by PCR. Primers: VIM1F (5'-CAG-ATT-96 
GCC-GAT-GGT-GGT-TGG-3') and VIM1R (5'-AGG-TGG-GCC-ATT-CAG-CCA-GA-3')  97 
were used to amplify blaVIM genes. whereas primers IMP-A (5-GAA-GGY-GTT-TAT-GTT-98 
CAT-AC-3') and IMP-B (5'-GTA-MGT-TTC-AAG-AGT-GAT-GC-3') [1] were used for 99 
detection of blaIMP genes. The cycling conditions were as follows: 94°C-5min, and then 30 100 
cycles-94°C-1 min, 55°C-1 min, 72°C-1-min and final extension at 72°C for 5 min. PCR 101 
products were subjected to electrophoresis in agarose gel at 100 V. PCR products were 102 
detected under UV light after staining with etidium bromide.  103 
 The amplicons were sequenced from both sides.  104 
Plasmid analyis 105 
Plasmids were extracted by alkaline lysis method as described previously [10]. Overnight 106 
cultures of the test strains in LB broth (12 ml) were centrifuged at 14 000 rpm and the pellet 107 
was resuspended in Solution I (25 mM Tris Hcl (pH 8), 50 mM Glucose, 10 mM EDTA (pH 108 
8) containing 5 mg/ml lysozyme and 10 mg/ml RNA-se. The suspensions were mixed and 109 
incubated on ice for 10 min before addition of the Solution II (0.2 N NaOH, 1% SDS). The 110 
samples were then mixed genty by inversion of the tubes. After incubation on ice for 15 min, 111 
Solution III was added (3 M K-Ac, pH 4.8). Solution III contained 120 ml 5 M K-Ac, 23 ml 112 
gliacil acetic acid and 57 ml H20. Samples were again mixed by inversion of the tubes, 113 
incubated on ice for 15 min and centrifuged for 15 min at 14 000 rpm at room temperature.  114 
The supernatant was transferred to the  clean tube avoiding any floating precipitate. Equal 115 
volume of phenol/chlorophorm was added, samples were mixed and centrifuged for 5 min. 116 
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This step was repeated twice. The supernatant was transferred to the clean tube without 117 
touching the water /chlorophorm interface or the precipitate in this region and 0.6 volumes of 118 
isopropanol were added.   The samples were incubated 30 min at room temperature and 119 
centrifuged at 14 000 rpm for 20 min. The supernatant was discarded and the pellet dried in 120 
the vacuum centrifuge. The pellet was washed once with 70% ethanol and resuspended in TE 121 
buffer. Samples were subjected to electrophoresis in  0.7 %  agarose gel in TBE buffer. After 122 
staining with ethidium bromide, the DNA was visualised by ultraviolet light. 123 
 124 
Genotyping of strains by pulsed-field gel electrophoresis 125 
Isolation of chromosomal DNA was performed as described by Kaufman et al [11]. For each 126 
isolate 1,0 ml (optical suspension density 0,6-0,7 at 540 nm) of an overnight culture grown in 127 
BHI broth was pelleted by centrifugation at 10 000 rpm for 2 min. After being washed in 1 ml 128 
SE buffer (75mM  NaCl;25mM EDTA, Sigma), bacteria were resuspended in 500µl SE buffer 129 
with 10 µl lysosime (Boehringer Mannheim GmbH). Next, 500 µl of this bacterial suspension 130 
was mixed with 500 µl 2,0% low- melting-temperature agarose (InCert agarose; FMC 131 
Bioproducts) and left to solidify. Solid agarose plugs were then incubated for 24h at 560 C in 132 
2ml of ESP buffer (1% N-lauril sarcosine; 0,5 M EDTANa2, pH 9,5; 500 µg/ml proteinase K, 133 
Sigma). After 24h, the plugs were incubated at room temperature for 2 h in PMSF 134 
(phenylmethanesulfonyl-fluoride, Aldrich) and then  washed three  times for 30 min at 40 C 135 
with TE buffer (10mM Tris-Hcl,pH 8, 0,1 mM EDTA, Sigma) before macrorestriction with 136 
10U / 1 µl  XbaI for 3 h at 370 C. Restriction fragments of DNA were separated by PFGE with 137 
a CHEF-DRIII apparatus (Bio-Rad Laboratories) through 1% pulsed-field certified agarose 138 
(Bio-Rad)  at a field strength of 6 V/cm for 20 h at 110 C; with pulses from 5  to 50 -s in 0,5 139 
TBE buffer with thiurea (50mM, Sigma). A lambda ladder (Roche) was used as the molecular 140 
size marker. After electrophoresis, gels were stained with ethidium bromide, rinsed, and 141 
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photographed under UV light. The PFGE patterns were compared following the criteria of 142 
Tenover and coleagues for bacterial strain typing [12] and analysed by computer software 143 
(GelComparII). The patterns obtained were compared by clustering methods (unweighted 144 
pairgroup method with arithmetic averages) using the Dice coefficient. An optimization of 145 
0,50% and position tolerance of 3,00% were applied during the comparison of PFGE 146 
fingerprinting patterns.    147 
 148 
Characterization of outer membrane proteins 149 
Outer membrane proteins of six MBL positive P. aeruginosa strains were prepared as 150 
described previously [13]. Cells were harvested from overnight cultures in LB broth and 151 
resuspended in phosphate buffer. Proteins were released from the cells by sonication in ice 152 
bath and collected by centrifugation at 10 000 g. After solubilization in 10 mM Tris HCl , 5 153 
mM MgCl2 and to 2% sodium lauroyl sarconisate for  for 1 h at 37°C the insoluble OMPs 154 
were recovered at 14 000 g. A second solubilization step was performed and the OMPs were 155 
again pelleted as above. Prior to SDS PAGE, the OMPs were  denatured by the addition of 156 
3% SDS-5% β-mercaptoethanol and boiled for 10 min. Laemmli’s  sample buffer (62.5 mM 157 
Tris/Hcl, 2% SDS, 10% glycerol, 5% mercaptoethanol) and electrode buffer (25 mM Tris (pH 158 
8.3), 190 mM glycine, 0.1% SDS) were used.  159 
Electrophoretic analysis of P. aeruginosa OMPs was performed in polyacrylamide gel. The 160 
gel contained 11% acrylamide, 0.54% bisacrylamide plus 0.2% SDS in 0.375 M Tris/HCl (pH 161 
8.8). Gel was polymerised with 0.2% TEMED and 0.25% ammonium persulfate. Stacking gel 162 
contained 4% acrylamide, 0.1% bisacrylamide, 0.1% SDS in 0.125 M Tris /HCl (pH 6.8), and 163 
was polymerised as above. Staining was performed with 0.125% Coomassie brilliant blue 164 
R250 in 45% methanol, 10% acetic acid for about 30 min. Destaining was performed in 45% 165 
methanol, 10% acetic acid.  166 
167 
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RESULTS 168 
E test 169 
Six out of 100 isolates were positive for MBLs by E test.  170 
Prevalence 171 
The prevalence of MBLs among carbapenem resistant isolates of P. aeruginosa was 6%.  172 
Susceptibility testing 173 
All strains were resistant to gentamicin, ceftazidime and cefotaxime.  All except of strain 174 
(132) were resistant to imipenem. Strains 6, 12, 132 and 135 were resistant to ciprofloxacin, 175 
strains 12, 22, 35 and 135 to aztreonam, strains 6, 12, 22 and 135 to cefoperazon and strains 176 
22, 35 and 135 to cefepime. Resistance to piperacillin alone and combined with tazobactam 177 
was observed in only one strain (135).  178 
Enzyme characterization 179 
The enzyme activity ranged from6 to 420 nmol/imipenem/min/mg of protein. Carbapenemase 180 
activity was almost completely inhibited by 2 mM EDTA. (Table 2)  . 181 
IEF revealed a band with the pI of 5.3 in all strains.  182 
Polymerase chain reaction and sequencing of blaVIM genes 183 
Six strains yielded an amplicon of 523 bp with primers specific for VIM β-lactamases. 184 
Sequencing of blaVIM genes revealed the production of VIM-2 β-lactamase in all six strains 185 
(Fig. 1). No IMP MBLs producers were detected by PCR.  186 
Plasmid analysis 187 
No plasmid DNA was found.  188 
Pulsed field gel electrophoresis  189 
The strains showed distinct PFGE patterns and were not clonally related  (Fig. 2).  190 
Characterization of outer membrane proteins 191 
Four of the tested strains lacked altered OmpD2 protein (Table 1).  192 
193 
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DISCUSSION 194 
This investigation proved the occurence of VIM-2 β-lactamase among P. aeruginosa strains 195 
from Zagreb, Croatia. VIM-2 β -lactamase was previously reported from another region in 196 
Croatia [14] suggesting that there is a regional spread of this resistance determinant. VIM-2 β 197 
-lactamase with similar properties was previously described in Italy [15], France  [16], Spain 198 
[17], Greece [18], Taiwan [19] and South Korea [20] suggesting that this type of enzyme is 199 
widespread in Mediterreanean region of Europe and Far East. VIM-2 is the most prevalent 200 
MBL in Taiwan [21].  201 
The fact that all strains displayed similar enzyme activities, but one strain (132) showed 202 
markedly lower carbapenem MIC than the others suggests that there are other resistance 203 
mechanisms involved in the strains with high carbapenem MIC such as loss of outer 204 
membrane proteins detected in four strains (6, 12, 22, 135) or efflux. The strain with low 205 
carbapenem MIC probably had higher permeability coefficient or less efficient efflux pump. 206 
However, the carbapenem MICs rose above the resistance breakpoint for the strain 132 when 207 
a higher inoculum which is more likely to occur in in vivo situation, was applied. It is possible 208 
that in vivo in the presence of a high inoculum, high level resistance arises. Little clinical 209 
information is available on the outcome of patients infected with carbapenem-susceptible 210 
MBL producing P. aeruginosa. There is no concensus on the interpretation and reporting of 211 
the antibiograms for the MBL producers. Four strains were resistant to aztreonam contrary to 212 
the results obtained from other authors [16-17,22]. Aztreonam is not hydrolyzed by MBLs [1] 213 
but resistance could be due to other mechanisms like overproduction of AmpC β–lactamase, 214 
coexistace of other β-lactamase or efflux as reported previously [23].  The macrorestriction of 215 
the Xba digested chromosomal DNA showed distinct patterns indicating that strains 216 
harbouring blaVIM genes are not clonally related. Thus it is more likely that the spread of MBL 217 
genes is due to the genetic exchange between different clones.  The occurence of MBLs was 218 
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sporadic. The strains were obtained from various wards in two hospitals during a wide time 219 
period.   220 
Since all three attempts to transfer ceftazidime resistance to recipient strain and to isolate 221 
plasmid DNA were unsuccessful we can conclude that gene cassettes harbouring blaVIM genes 222 
were located in the integrons [20] which are inserted in the chromosome and that their 223 
dissemination in Croatia is due to the mobilization of the resistance genes.  224 
Our strains harbouring VIM-2 β -lactamase were resistant to all β -lactam antibiotics, 225 
aminoglycosides and fluoroquinolones and pose a serious therapeutic problem in our 226 
hospitals. The fact that all strains were resistant to gentamicin suggests that blaVIM genes are 227 
located on integrons containing gene casettes with resistance determinants for 228 
aminoglycosides.  Since most of the strains were resistant to aminoglycosides and 229 
fluoroquinolones as well only toxic compounds such as colistine are left to be administered as 230 
a therapeutic agent. The prevalence of MBL positive P. aeruginosa among our carbapenem 231 
resistant strains of this species is still low (6%) but there is a possibility of horizontal spread 232 
of blaVIM genes to Enterobacteriaceae which are more frequent pathogens. MBLs have 233 
already been found in the members of the family Enterobacteriaceae [18-19].The difficulties 234 
in detecting MBLs producers in the routine laboratories together with the mobile nature of the 235 
gene cassettes carrying blaVIM genes facilitates their dissemination. Meropenem has been 236 
extensively used in our hospitals and the presence of MBLs among carbapenem resistant 237 
 P. aeruginosa of different genotypes, isolated from different hospitals, although in low 238 
frequency, underscores the need for restricted use of carbapenems and their systematic 239 
surveillance. Constant and consistent surveillance of the MBL producing strains will be the 240 
prime measure to prevent their further dissemination.  241 
242 
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Table1. Epidemiologic characteristics, minimum inhibitory concentrations (MIC) of various antibiotics against MBL positive P. aeruginosa strains and alteration of 
outer membrane proteins.  
 
 Epidemiologic chracteristics of P. aeruginosa strains MIC (mg/L)1 Porins 
Strain 
No 
Specimen Hospital2 Unit 
PFGE 
type 
Date of 
isolation 
(D/M/Y) 
IMI MEM CAZ CAZ/CL CTX CFP FEP AMT PIP TZP GM CIP OMPD2 
6 urine A nephrology 1 
15/01/2004 
>128 64 16 >128 >128 >128 16 8 64 32 >128 16 
- 
12 stool A haematology 2 
14/01/2003 
64 32 >128 >128 32 >128 16 >128 64 32 >128 64 
- 
22 Tracheal 
aspirate 
A 
Paediatric 
ICU 
3 
15/02/2003 
>128 32 32 64 >128 16 64 >128 32 16 64 0.5 
- 
35 Wound 
swab 
A oncology 4 
25/02/2003 
>128 32 16 32 32 4 32 >128 64 32 >128 4 
+ 
132 Tracheal 
aspirate 
B 
Surgery 
ICU 
4 
09/08/2003 
16 8 >128 >128 64 4 16 0.12 32 8 16 32 
+ 
135 Bronchal 
aspirate 
B 
Internal 
ICU 
5 
07/01/2002 
>128 64 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 
- 
 
                                                                                 
1
 Abbreviations-IMI-imipenem, MEM-meropenem, CAZ-ceftazidime, CAZ/CL-ceftazidime+clavulanic acid, CTX-cefotaxime, CFP-cefoperazone, FEP-cefepime, AMT-aztreonam, PIP-piperacillin, 
TZP-Tazobactam/piperacillin, GM-gentamicin, CIP-ciprofloxacin 
2
 A- University Hospital Center-Zagreb, B-University Hospital Merkur 
  
Table 2. Hydrolysis rates against imipenem of metallo-β-lactamases produced by P. aeruginosa  strains.  
 
Strain No Hydrolysis rate 
(nmol/min/mg protein) 
 
Hydrolysis rate in the presence of 2 mM 
EDTA 
(nmol/min/mg protein) 
6 6 x 10
-9
 1 x 10
-13
 
12 9 x 10
-9
 1.8 x 10
-11
 
22 4.2 x 10
-8
 9.4 x 10
-12
 
35 4 x 10
-8
 3.8 x 10
-12
 
132 3.5 x 10
-8
 2.7 x 10
-10
 
135 4 x 10
-8
 1.2 x 10
-9
 
 
